Angiopoietin-2 blockade suppresses growth of liver metastases from pancreatic neuroendocrine tumors by promoting T cell recruitment

Improving the management of metastasis in pancreatic neuroendocrine tumors (PanNETs) is critical, as nearly half of patients with PanNETs present with liver metastases, and this accounts for the majority of patient mortality. We identified angiopoietin-2 (ANGPT2) as one of the most upregulated angio...

Full description

Bibliographic Details
Main Authors: Eunhyeong Lee, Sophie O’Keefe, Alessandra Leong, Ha-Ram Park, Janani Varadarajan, Subrata Chowdhury, Shannon Hiner, Sungsoo Kim, Anahita Shiva, Richard A. Friedman, Helen Remotti, Tito Fojo, Hee Won Yang, Gavin Thurston, Minah Kim
Format: Article
Language:English
Published: American Society for Clinical Investigation 2023-10-01
Series:The Journal of Clinical Investigation
Subjects:
Online Access:https://doi.org/10.1172/JCI167994
_version_ 1797634472271675392
author Eunhyeong Lee
Sophie O’Keefe
Alessandra Leong
Ha-Ram Park
Janani Varadarajan
Subrata Chowdhury
Shannon Hiner
Sungsoo Kim
Anahita Shiva
Richard A. Friedman
Helen Remotti
Tito Fojo
Hee Won Yang
Gavin Thurston
Minah Kim
author_facet Eunhyeong Lee
Sophie O’Keefe
Alessandra Leong
Ha-Ram Park
Janani Varadarajan
Subrata Chowdhury
Shannon Hiner
Sungsoo Kim
Anahita Shiva
Richard A. Friedman
Helen Remotti
Tito Fojo
Hee Won Yang
Gavin Thurston
Minah Kim
author_sort Eunhyeong Lee
collection DOAJ
description Improving the management of metastasis in pancreatic neuroendocrine tumors (PanNETs) is critical, as nearly half of patients with PanNETs present with liver metastases, and this accounts for the majority of patient mortality. We identified angiopoietin-2 (ANGPT2) as one of the most upregulated angiogenic factors in RNA-Seq data from human PanNET liver metastases and found that higher ANGPT2 expression correlated with poor survival rates. Immunohistochemical staining revealed that ANGPT2 was localized to the endothelial cells of blood vessels in PanNET liver metastases. We observed an association between the upregulation of endothelial ANGPT2 and liver metastatic progression in both patients and transgenic mouse models of PanNETs. In human and mouse PanNET liver metastases, ANGPT2 upregulation coincided with poor T cell infiltration, indicative of an immunosuppressive tumor microenvironment. Notably, both pharmacologic inhibition and genetic deletion of ANGPT2 in PanNET mouse models slowed the growth of PanNET liver metastases. Furthermore, pharmacologic inhibition of ANGPT2 promoted T cell infiltration and activation in liver metastases, improving the survival of mice with metastatic PanNETs. These changes were accompanied by reduced plasma leakage and improved vascular integrity in metastases. Together, these findings suggest that ANGPT2 blockade may be an effective strategy for promoting T cell infiltration and immunostimulatory reprogramming to reduce the growth of liver metastases in PanNETs.
first_indexed 2024-03-11T12:08:17Z
format Article
id doaj.art-eaf9a3bca30a429d8677f001514daa1e
institution Directory Open Access Journal
issn 1558-8238
language English
last_indexed 2024-03-11T12:08:17Z
publishDate 2023-10-01
publisher American Society for Clinical Investigation
record_format Article
series The Journal of Clinical Investigation
spelling doaj.art-eaf9a3bca30a429d8677f001514daa1e2023-11-07T16:20:59ZengAmerican Society for Clinical InvestigationThe Journal of Clinical Investigation1558-82382023-10-0113320Angiopoietin-2 blockade suppresses growth of liver metastases from pancreatic neuroendocrine tumors by promoting T cell recruitmentEunhyeong LeeSophie O’KeefeAlessandra LeongHa-Ram ParkJanani VaradarajanSubrata ChowdhuryShannon HinerSungsoo KimAnahita ShivaRichard A. FriedmanHelen RemottiTito FojoHee Won YangGavin ThurstonMinah KimImproving the management of metastasis in pancreatic neuroendocrine tumors (PanNETs) is critical, as nearly half of patients with PanNETs present with liver metastases, and this accounts for the majority of patient mortality. We identified angiopoietin-2 (ANGPT2) as one of the most upregulated angiogenic factors in RNA-Seq data from human PanNET liver metastases and found that higher ANGPT2 expression correlated with poor survival rates. Immunohistochemical staining revealed that ANGPT2 was localized to the endothelial cells of blood vessels in PanNET liver metastases. We observed an association between the upregulation of endothelial ANGPT2 and liver metastatic progression in both patients and transgenic mouse models of PanNETs. In human and mouse PanNET liver metastases, ANGPT2 upregulation coincided with poor T cell infiltration, indicative of an immunosuppressive tumor microenvironment. Notably, both pharmacologic inhibition and genetic deletion of ANGPT2 in PanNET mouse models slowed the growth of PanNET liver metastases. Furthermore, pharmacologic inhibition of ANGPT2 promoted T cell infiltration and activation in liver metastases, improving the survival of mice with metastatic PanNETs. These changes were accompanied by reduced plasma leakage and improved vascular integrity in metastases. Together, these findings suggest that ANGPT2 blockade may be an effective strategy for promoting T cell infiltration and immunostimulatory reprogramming to reduce the growth of liver metastases in PanNETs.https://doi.org/10.1172/JCI167994Angiogenesis
spellingShingle Eunhyeong Lee
Sophie O’Keefe
Alessandra Leong
Ha-Ram Park
Janani Varadarajan
Subrata Chowdhury
Shannon Hiner
Sungsoo Kim
Anahita Shiva
Richard A. Friedman
Helen Remotti
Tito Fojo
Hee Won Yang
Gavin Thurston
Minah Kim
Angiopoietin-2 blockade suppresses growth of liver metastases from pancreatic neuroendocrine tumors by promoting T cell recruitment
The Journal of Clinical Investigation
Angiogenesis
title Angiopoietin-2 blockade suppresses growth of liver metastases from pancreatic neuroendocrine tumors by promoting T cell recruitment
title_full Angiopoietin-2 blockade suppresses growth of liver metastases from pancreatic neuroendocrine tumors by promoting T cell recruitment
title_fullStr Angiopoietin-2 blockade suppresses growth of liver metastases from pancreatic neuroendocrine tumors by promoting T cell recruitment
title_full_unstemmed Angiopoietin-2 blockade suppresses growth of liver metastases from pancreatic neuroendocrine tumors by promoting T cell recruitment
title_short Angiopoietin-2 blockade suppresses growth of liver metastases from pancreatic neuroendocrine tumors by promoting T cell recruitment
title_sort angiopoietin 2 blockade suppresses growth of liver metastases from pancreatic neuroendocrine tumors by promoting t cell recruitment
topic Angiogenesis
url https://doi.org/10.1172/JCI167994
work_keys_str_mv AT eunhyeonglee angiopoietin2blockadesuppressesgrowthoflivermetastasesfrompancreaticneuroendocrinetumorsbypromotingtcellrecruitment
AT sophieokeefe angiopoietin2blockadesuppressesgrowthoflivermetastasesfrompancreaticneuroendocrinetumorsbypromotingtcellrecruitment
AT alessandraleong angiopoietin2blockadesuppressesgrowthoflivermetastasesfrompancreaticneuroendocrinetumorsbypromotingtcellrecruitment
AT harampark angiopoietin2blockadesuppressesgrowthoflivermetastasesfrompancreaticneuroendocrinetumorsbypromotingtcellrecruitment
AT jananivaradarajan angiopoietin2blockadesuppressesgrowthoflivermetastasesfrompancreaticneuroendocrinetumorsbypromotingtcellrecruitment
AT subratachowdhury angiopoietin2blockadesuppressesgrowthoflivermetastasesfrompancreaticneuroendocrinetumorsbypromotingtcellrecruitment
AT shannonhiner angiopoietin2blockadesuppressesgrowthoflivermetastasesfrompancreaticneuroendocrinetumorsbypromotingtcellrecruitment
AT sungsookim angiopoietin2blockadesuppressesgrowthoflivermetastasesfrompancreaticneuroendocrinetumorsbypromotingtcellrecruitment
AT anahitashiva angiopoietin2blockadesuppressesgrowthoflivermetastasesfrompancreaticneuroendocrinetumorsbypromotingtcellrecruitment
AT richardafriedman angiopoietin2blockadesuppressesgrowthoflivermetastasesfrompancreaticneuroendocrinetumorsbypromotingtcellrecruitment
AT helenremotti angiopoietin2blockadesuppressesgrowthoflivermetastasesfrompancreaticneuroendocrinetumorsbypromotingtcellrecruitment
AT titofojo angiopoietin2blockadesuppressesgrowthoflivermetastasesfrompancreaticneuroendocrinetumorsbypromotingtcellrecruitment
AT heewonyang angiopoietin2blockadesuppressesgrowthoflivermetastasesfrompancreaticneuroendocrinetumorsbypromotingtcellrecruitment
AT gavinthurston angiopoietin2blockadesuppressesgrowthoflivermetastasesfrompancreaticneuroendocrinetumorsbypromotingtcellrecruitment
AT minahkim angiopoietin2blockadesuppressesgrowthoflivermetastasesfrompancreaticneuroendocrinetumorsbypromotingtcellrecruitment